// App-Quantinova.ai

: Long-Term Analysis of an Open-Label, Multicentre, Randomized Phase 3 Trial Comparing Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine As a Preparative Regimen for Allogeneic Stem-Cell Transplantation in Patients with Acute Myeloid Leukemia

Researchers

Presenter

  • Gianluca Cavallaro

Principal Investigators

  • Chiara Pavoni

  • MARIA CATERINA MICO'

  • Alessandro Busca

  • Irene Maria Cavattoni

  • Stella Santarone

  • Carlo Borghero

  • Attilio Olivieri

  • Giuseppe Milone

  • Patrizia Chiusolo

  • Pellegrino Musto

  • Riccardo Saccardi

  • Francesca Patriarca

  • Fabrizio Pane

  • Giorgia Saporiti

  • Paolo Rivela

  • Elisabetta Terruzzi

  • Raffaella Cerretti

  • Giuseppe Marotta

  • Angelo Michele Carella

  • Arnon Nagler

  • Domenico Russo

  • Paolo Corradini

  • Paolo Bernasconi

  • Anna Paola Iori

  • Luca Castagna

  • Nicola Mordini

  • Elena Oldani

  • Carmen Di Grazia

  • Andrea Bacigalupo

  • Alessandro Rambaldi

Medical Centers

  • Ospedale Civile, Pescara, Italy

  • Dipartimento di Ematologia, Ospedale San Bortolo, Vicenza, Italy

  • Azienda Ospedaliera Universitaria Senese, Siena, ITA

  • Santa Croce e Carle Hospital, Division of Haematology, Cuneo, Italy

  • Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Milan, Italy

  • UOSD Trapianto di Midollo, Ospedale Villa Sofia Cervello, Palermo, Italy

  • Ematologia e TMO, Ospedale di Bolzano, Azienda Sanitaria Alto Adige, Bolzano, Italy

  • Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, ASST Spedali Civili, Brescia, Italy

  • SSD Trapianto Cellule Staminali, AOU Citta' della Salute e della Scienza, Torino, Italy

  • Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy

  • Hematology, Department of Translational and Precision Medicine, AOU Policlinico Umberto I, Sapienza University of Rome, Roma, Italy

  • Hematology Division, San Gerardo Hospital, Monza, Italy

  • UO ematologia e terapie cellulari, IRCCS Ospedale Policlinico San martino, Genova, Italy

  • HSCT Unit, UOC Ematologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy

  • Dipartimento Medicina Clinica e Chirurgia, UOC Ematologia e Trapianti di Midollo, Azienda Ospedaliera Universita Federico II, Napoli, Italy

  • Ematologia e Centro Trapianto CSE, Fondazione Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy

  • Universita Politecnica delle Marche, Ancona, Italy

  • Ematologia, Fondazione Universitaria Policlinico Gemelli IRCCS, Rome, Italy

  • Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy

  • Università degli Studi di Milano and Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCSS) Istituto Nazionale dei Tumori, Milan, Italy

  • Division of Hematology, A.O. SS Antonio e Biagio and Cesare Arrigo, Alessandria, Italy

  • Azienda Ospedaliero Universitaria Careggi, Firenze, Italy

  • Hematology Division-Stem Cell Transplant Unit, Policlinico Tor Vergata, Rome, Italy

  • Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel

Locations

  • Italy

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Autoimmune (AI)

Disease

  • Acute myelocytic leukemia

  • Graft-versus-host disease

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • fludarabine tablet

  • Busulfan

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

  • Multicenteric

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved